Biotechnology · Healthcare
General Counsel
2026-06-30–present
General Counsel
Alx Oncology Holdings Inc (ALXO)Equibles does not estimate personal net worth.
Get an email with a short summary when Alx Oncology Holdings Inc publishes a filing, an earnings call transcript or a press release.
Get ALXO alertsMichael Listgarten is recorded as General Counsel at Alx Oncology Holdings Inc (ALXO) since June 30, 2026. Alx Oncology Holdings Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alx Oncology Holdings Inc includes Jason Lettmann (CEO and Board Member), Scott Garland (Chairman and Board Member), Harish Shantharam (CFO) and 7 others.
2026-06-30–present
Biotechnology · Healthcare
General Counsel
2026-06-30–present
No call appearances or filed executive changes recorded yet.